Prezados(as)

As aulas da disciplina F. Autonômica (Colinérgicos e Anticolinérgicos) iniciam-se na próxima quinta feira (28/3), às 08h30 no Auditório do NPPM.

Seguem abaixo as datas, os artigos e os apresentadores dos seminários.

PS: Atentem para baixar o artigo correto da sua apresentação; para isso, cada artigo tem seu próprio DOI - Identificador de Objeto Digital).

At.te

Prof Fco Oliveira

APRESENTAÇÕES:

Quinta-feira 28/03:

#Seminário 1 (DEBORA CAROLINE / HENGRID GRACIELY)

Tuleen Alkawadri et al. M2 muscarinic receptor-dependent contractions of airway smooth muscle are inhibited by activation of β-Adrenoceptors. Function, 2022, 3(6): zqac050 (https://doi.org/10.1093/function/zqac050).

 #Seminário 2 (JOSE MOREIRA/MARCOS LIMA)

Latifa Khalfaoui et al. Functional alfa7 nicotinic receptors in human airway smooth muscle increase intracellular calcium concentration and contractility in asthmatics. Am J Physiol Lung Cell Mol Physiol 325:L17– L 29,2023. (doi:1 0.1152/ajplung.00260.2022).

 Quinta-feira 04/03:

#Seminário 3 (MARIA DOS REMEDIOS/MATEUS LIMA)

Baban S. Thawkar et al. Betanin mitigates scopolamineinduced cognitive impairment by restoring cholinergic function, boosting brain antioxidative status, and increasing BDNF level in the zebrafsh model. Fish Physiol Biochem (2023) 49:335–349. (https://doi.org/10.1007/s10695-023-01185-6)

 #Seminário 4 (NADIA VERAS/NATALIA DE ASSIS)

 Magdolna K. Levay et al. The Muscarinic Acetylcholine M2 Receptor-Induced Nitration of  p190A by eNOS Increases RhoA Activity in Cardiac Myocytes. (https://doi.org/10.3390/cells12202432).

 Quinta-feira 11/04:

#Seminário 5 (PEDRINA MORGANA/ROBERTA CARNEIRO)

Nanthip Prathumsap et al. Acetylcholine receptor agonists provide cardioprotection in doxorubicin-induced cardiotoxicity via modulating muscarinic M2 and a7 nicotinic receptor expression. Translational Research, vol 243, 2022. (https://doi.org/10.1016/j.trsl.2021.12.005)

 #Seminário 6 (SAMUEL DE SOUSA/TALLES VITOR)

Junqing An et al. Nicotine exacerbates atherosclerosis and plaque instability via NLRP3 inflammasome activation in vascular smooth muscle cells. Theranostics, 2023; 13(9): 2825-2842. (doi: 10.7150/thno.81388).

 Quinta-feira 18/04:

#Seminário 7 (TATILLA LUZ/VALERIA ALVES)

 Steven M. Paul et al. Muscarinic acetylcholine receptor agonists as novel treatments for schizophrenia. Am J Psychiatry 2022; 179:611–627 (doi: 10.1176/appi.ajp.21101083)

#Seminário 8 (WANDERLEY DO NASCIMENTO)

Lydia J. Bye  et al. Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases. International Journal of Biochemistry and Cell Biology, 157 (2023) 106387 (https://doi.org/10.1016/j.biocel.2023.106387).